These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 30950290)

  • 1. When 10 is enough: Errors on the first 10 items of the Test of Memory Malingering (TOMMe10) and administration time predict freestanding performance validity tests (PVTs) and underperformance on memory measures.
    Denning JH
    Appl Neuropsychol Adult; 2021; 28(1):35-47. PubMed ID: 30950290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Minimizing evaluation time while maintaining accuracy: Cross-validation of the Test of Memory Malingering (TOMM) Trial 1 and first 10-item errors as briefer performance validity tests.
    Kraemer LDR; Soble JR; Phillips JI; Webber TA; Fullen CT; Highsmith JM; Alverson WA; Critchfield EA
    Psychol Assess; 2020 May; 32(5):442-450. PubMed ID: 32027161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combining the test of memory malingering trial 1 with behavioral responses improves the detection of effort test failure.
    Denning JH
    Appl Neuropsychol Adult; 2014; 21(4):269-77. PubMed ID: 25265308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The efficiency and accuracy of the Test of Memory Malingering trial 1, errors on the first 10 items of the test of memory malingering, and five embedded measures in predicting invalid test performance.
    Denning JH
    Arch Clin Neuropsychol; 2012 Jun; 27(4):417-32. PubMed ID: 22543569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Performance on the Test of Memory Malingering is predicted by the number of errors on its first 10 items on an inpatient epilepsy monitoring unit.
    Grabyan JM; Collins RL; Alverson WA; Chen DK
    Clin Neuropsychol; 2018 Apr; 32(3):468-478. PubMed ID: 28826306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TOMM Trial 1 as a performance validity indicator in a criminal forensic sample.
    Fazio RL; Denning JH; Denney RL
    Clin Neuropsychol; 2017 Jan; 31(1):251-267. PubMed ID: 27456971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Test of memory malingering with children: The utility of Trial 1 and TOMMe10 as screeners of test validity.
    Loughan AR; Perna R; Le J
    Child Neuropsychol; 2016; 22(6):707-17. PubMed ID: 26031205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Examining the cross-cultural validity of the test of memory malingering and the Rey 15-item test.
    Crişan I; Erdodi L
    Appl Neuropsychol Adult; 2024; 31(5):721-731. PubMed ID: 35476611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The TOMM1 discrepancy index (TDI): A new performance validity test (PVT) that differentiates between invalid cognitive testing and those diagnosed with dementia.
    Denning JH
    Appl Neuropsychol Adult; 2023; 30(1):83-90. PubMed ID: 33945362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of race and other demographic factors on the false positive rates of five embedded Performance Validity Tests (PVTs) in a Veteran sample.
    Denning JH; Horner MD
    J Clin Exp Neuropsychol; 2024 Feb; 46(1):25-35. PubMed ID: 38353039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical utility of the Rey 15-Item Test, recognition trial, and error scores for detecting noncredible neuropsychological performance in a mixed clinical sample of veterans.
    Bailey KC; Soble JR; O'Rourke JJF
    Clin Neuropsychol; 2018 Jan; 32(1):119-131. PubMed ID: 28555516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decision rules for an abbreviated administration of the Test of Memory Malingering.
    Ashendorf L; Withrow S; Ward SH; Sullivan SK; Sugarman MA
    Appl Neuropsychol Adult; 2024; 31(4):382-391. PubMed ID: 35068279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluating the Medical Symptom Validity Test (MSVT) in a Sample of Veterans Between the Ages of 18 to 64.
    Reslan S; Axelrod BN
    Appl Neuropsychol Adult; 2017; 24(2):132-139. PubMed ID: 27045467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psychometric implications of failure on one performance validity test: a cross-validation study to inform criterion group definition.
    Rhoads T; Neale AC; Resch ZJ; Cohen CD; Keezer RD; Cerny BM; Jennette KJ; Ovsiew GP; Soble JR
    J Clin Exp Neuropsychol; 2021 Jul; 43(5):437-448. PubMed ID: 34233580
    [No Abstract]   [Full Text] [Related]  

  • 15. Using the Memory Validity Profile (MVP) to detect invalid performance in youth with mild traumatic brain injury.
    Brooks BL; Sherman EMS
    Appl Neuropsychol Child; 2019; 8(4):319-325. PubMed ID: 29963927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Establishing supplementary response time validity indicators in the Word Memory Test (WMT) and directions for future research.
    Elbaum T; Golan L; Lupu T; Wagner M; Braw Y
    Appl Neuropsychol Adult; 2020; 27(5):403-413. PubMed ID: 30724595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Not all performance validity tests are created equal: The role of recollection and familiarity in the Test of Memory Malingering and Word Memory Test.
    Eglit GM; Lynch JK; McCaffrey RJ
    J Clin Exp Neuropsychol; 2017 Mar; 39(2):173-189. PubMed ID: 27501116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. When Failing One Performance Validity Test Matters.
    Denning JH
    Appl Neuropsychol Adult; 2023 Dec; ():1-12. PubMed ID: 38065580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cross-validation of the Trail Making Test as a non-memory-based embedded performance validity test among veterans with and without cognitive impairment.
    Peak AM; Marceaux JC; Chicota-Carroll C; Soble JR
    J Clin Exp Neuropsychol; 2024 Feb; 46(1):16-24. PubMed ID: 38007610
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the classification accuracy of multiple performance validity tests in a mixed clinical sample.
    Messerly J; Soble JR; Webber TA; Alverson WA; Fullen C; Kraemer LD; Marceaux JC
    Appl Neuropsychol Adult; 2021; 28(6):727-736. PubMed ID: 31835915
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.